摘要:
An antibiotic complex, consisting of two major components, has been isolated from fermentations of a new subspecies of Streptomyces albus culture. The two major components from the complex are two new macrolide antibiotics, which are active as antibacterial agents against certain gram-positive and gram-negative microorganisms.
摘要:
The present invention relates to product(s) containing living microorganism(s) suitable for soil treatment, microorganisms multiplying under different climatic and natural circumstances, as well as procedures for the production of the products, and procedures for the treatment of the soil and plants with the products. More particularly, the invention relates to a procedure for preparing the products from any of the microorganisms specified below, or from the mixture thereof. Furthermore, the invention relates to a procedure for the creation of the cultures of the microorganisms to be used. The subject invention also pertains to the microorganisms themselves. More particularly, the invention relates to a procedure for the treatment of the soil and the plants with a product containing at least one of the microorganisms selected from Azospirillum brasilense ssp. SW51 (NCAIM /P/ B 001293), Azotobacter vinelandii ssp. M657 (NCAIM /P/B 001292), Pseudomonas fluorescens var. SW11 (NCAIM /P/ B 001296), Bacillus polymyxa var. SW17 (NCAIM /P/ B 001295), Bacillus megaterium var. M326 (NCAIM /P/ B 001291), Micrococcus roseus ssp. A21 (NCAIM /P/B 001294), Bradyrhizobium japonicum var. PH25 (NCAIM /P/ B 001302), and Streptomyces albus var. 0003 LP (NCAIM /P/ B 001301), and furthermore the products multiplying and existing in the environment of the plant in question, containing the listed microorganisms and their production.
摘要翻译:本发明涉及含有适于土壤处理的活微生物,不同气候和天然环境下的微生物繁殖的产品,以及产品的生产程序,以及土壤和植物的处理程序 与产品。 更具体地说,本发明涉及从以下指定的任何微生物或其混合物制备产物的方法。 此外,本发明涉及用于产生待使用的微生物培养物的方法。 本发明也涉及微生物本身。 更具体地说,本发明涉及一种用含有至少一种微生物处理土壤和植物的方法,所述微生物选自巴西喷虫(Azospirillum brasilense ssp) SW51(NCAIM / P / B 001293),Azotobacter vinelandii ssp。 M657(NCAIM / P / B 001292),荧光假单胞菌变种 SW11(NCAIM / P / B 001296),多粘芽孢杆菌变种 SW17(NCAIM / P / B 001295),巨大芽孢杆菌变种 M326(NCAIM / P / B 001291),Micrococcus roseus ssp。 A21(NCAIM / P / B 001294),日本的Bradyrhizobium japonicum var。 PH25(NCAIM / P / B 001302)和链霉菌(Streptomyces albus var。 0003 LP(NCAIM / P / B 001301),此外,产品在相关工厂的环境中繁殖和存在,包含列出的微生物及其生产。
摘要:
The invention relates to new biologically active glycopeptides of the general formulaSacch--A--B--Rin which Sacch represents a monosaccharide residue with, where appropriate, the OH groups being partially or completely substituted,A represents the residue of a neutral L- or D-amino acid or --if B is absent--represents the residue of a neutral D-amino acid,B is absent or represents the residue of a neutral L- or D-amino acid or of an optionally .omega.-substituted bi-functional acidic or basic L- or D-amino acid, and R represents hydroxyl, (C.sub.1 -C.sub.8)-alkoxy, an amino radical which is optionally substituted by one or two identical or different radicals from the series comprising (C.sub.1 -C.sub.8)-alkyl, (C.sub.5 -C.sub.8)-cycloalkyl, (C.sub.5 -C.sub.8)-heteroalkyl or (C.sub.5 -C.sub.8)-heteroaryl, or another acid derivative. These compounds have enkephalinase-inhibiting properties and can thus be used, for example, as analgesics in human and veterinary medicine. The isolation of these compounds from Streptomyces albus ATCC 21838, and further processes for their preparation, are also described.
摘要:
An antibiotic complex, consisting of two major components, has been isolated from fermentations of a new subspecies of Streptomyces albus culture. The two major components from the complex are two new macrolide antibiotics, which are active as antibacterial agents against certain gram-positive and gram-negative microorganisms.
摘要:
The present invention relates to product(s) containing living microorganism(s) suitable for soil treatment, microorganisms multiplying under different climatic and natural circumstances, as well as procedures for the production of the products, and procedures for the treatment of the soil and plants with the products. More particularly, the invention relates to a procedure for preparing the products from any of the microorganisms specified below, or from the mixture thereof. Furthermore, the invention relates to a procedure for the creation of the cultures of the microorganisms to be used. The subject invention also pertains to the microorganisms themselves. More particularly, the invention relates to a procedure for the treatment of the soil and the plants with a product containing at least one of the microorganisms selected from Azospirillum brasilense ssp. SW51 (NCAIM /P/ B 001293), Azotobacter vinelandii ssp. M657 (NCAIM /P/B 001292), Pseudomonas fluorescens var. SW11 (NCAIM /P/ B 001296), Bacillus polymyxa var. SW17 (NCAIM /P/ B 001295), Bacillus megaterium var. M326 (NCAIM /P/ B 001291), Micrococcus roseus ssp. A21 (NCAIM /P/B 001294), Bradyrhizobium japonicum var. PH25 (NCAIM /P/ B 001302), and Streptomyces albus var. 0003 LP (NCAIM /P/ B 001301), and furthermore the products multiplying and existing in the environment of the plant in question, containing the listed microorganisms and their production.
摘要翻译:本发明涉及含有适于土壤处理的活微生物,不同气候和天然环境下的微生物繁殖的产品,以及产品的生产程序,以及土壤和植物的处理程序 与产品。 更具体地说,本发明涉及从以下指定的任何微生物或其混合物制备产物的方法。 此外,本发明涉及用于产生待使用的微生物培养物的方法。 本发明也涉及微生物本身。 更具体地说,本发明涉及一种用含有至少一种微生物处理土壤和植物的方法,所述微生物选自巴西喷虫(Azospirillum brasilense ssp) SW51(NCAIM / P / B 001293),Azotobacter vinelandii ssp。 M657(NCAIM / P / B 001292),荧光假单胞菌变种 SW11(NCAIM / P / B 001296),多粘芽孢杆菌变种 SW17(NCAIM / P / B 001295),巨大芽孢杆菌变种 M326(NCAIM / P / B 001291),Micrococcus roseus ssp。 A21(NCAIM / P / B 001294),日本的Bradyrhizobium japonicum var。 PH25(NCAIM / P / B 001302)和链霉菌(Streptomyces albus var。 0003 LP(NCAIM / P / B 001301),此外,产品在相关工厂的环境中繁殖和存在,包含列出的微生物及其生产。
摘要:
A new antitumor antibiotic designated herein as BMY-28121 is produced by fermentation of Streptomyces albus strain K7331-113 (ATCC 39897). BMY-28121, which may be recovered from the fermentation broth in either its natural free hydroxy form (BMY-28121A) or methyl ether form (BMY-28121B), inhibits gram-positive bacteria and anaerobes and inhibits the growth of mammalian tumors such as P-388 leukemia, L-1210 leukemia and B16 melanoma.
摘要:
A new antitumor antibiotic designated herein as BMY-28121 is produced by fermentation of Streptomyces albus strain K731-113 (ATCC 39897). BMY-28121, which may be recovered from the fermentation broth in either its natural free hydroxy form (BMY-28121A) or methyl ether form (BMY-28121B), inhibits gram-positive bacteria and anaerobes and inhibits the growth of mammalian tumors such as P-388 leukemia, L-1210 leukemia and B16 melanoma.
摘要:
Disclosed are processes for producing lipids for biofuel or lubricant and Streptomyces bacteria used in the processes. The processes include steps whereby bacterial cells of the germs Streptomyces are cultivated in a medium comprising organic waste(s) or residue(s) or mixtures thereof as carbon and/or nutrient source(s), wherein the organic waste(s) or residue(s) comprise lignocellulosic waste(s) or lignocellulosic residue(s), recovering lipids from the cells of the bacteria or from the cultivation medium, and using the recovered lipids or a fraction thereof as biofuel and/or lubricant, or as a starting material for biofuel and/or lubricant production.
摘要:
The present invention provides a process for producing lipids for biofuel or lubricant and Streptomyces bacteria used in the process. The process comprises cultivating bacterial cells of the genus Streptomyces in a medium comprising organic waste(s) or residue(s) or mixtures thereof as carbon and/or nutrient source(s), recovering lipids from the cells of said bacteria or from the cultivation medium, and using the recovered lipids or a fraction thereof as biofuel and/or lubricant, or as a starting material for biofuel and/or lubricant production.In addition, in one aspect the invention provides products obtained by using the process according to this disclosure.